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Abstract
Multiple	 Congenital	 Ocular	 Anomalities	 (MCOA)	 is	 a	 genetic	 disease	 that	
affects	 primarily	 Silver	 coloured	 horses	 of	 breeds	 such	 as	 the	 Rocky	 and	
Kentucky	mountain	 horses.	 In	 these	 breeds	 the	 Silver	 dapple	 colour	 is	 very	
popular	 leading	 to	 an	 increase	 of	 affected	 horses.	 The	 major	 feature	 of	 the	
disease	 is	 ocular	 cysts	 of	 variable	 size.	Large	 cysts	 also	 lead	 to	 a	 variety	 of	
secondary	syndromes,	for	example	retinal	detachment.	In	previous	studies	the	
locus	for	MCOA	has	been	mapped	to	an	interval	of	420	kb	on	equine	chromosome	
six.	Within	 this	 interval	 there	 are	 a	 number	 of	 genes	 including	 the	PMEL17	
gene	 that	 carry	 the	mutation	 that	 is	 believed	 to	 cause	 the	 Silver	 dapple	 coat	
color. This study has focused on shortening the interval by fine-mapping using 
Single	Nucleotide	Polymorphism	(SNP)	markers.	This	was	done	by	recovering	
polymorphic	markers	 from	 the	EcuCab	 2.0	 publication	 of	 equine	 SNPs.	 The	
genotyping	was	 carried	out	 using	preordered	primers	 and	probes	 in	 the	ABI	
7900HT	fast	real�time	PCR	system.	When	evaluating	the	results	two	different	
disease	haplotypes	were	detected,	one	longer	and	one	shorter.	These	recombinant	
chromosomes	helped	to	decrease	the	interval	by	37	%	resulting	in	an	interval	
of	25	kb.	This	reduced	the	number	of	genes	leaving	sixteen	to	be	investigated,	
including	the	PMEL17.	The	resulting	dataset	concurred	to	the	hypothesis	of	a	
codominant	 inheritance	pattern.	A	gene	within	 the	 interval	called	SMARCC2	
was	chosen	for	sequencing	due	to	its	known	importance	in	ocular	development.	
The	sequencing	exposed	a	polymorphism	in	the	intron	between	exon	nineteen	
and	twenty.	Following	studies	include	extended	investigation	of	the	SMARCC2	
polymorphism,	sequencing	of	other	candidate	genes	and	functional	studies	of	
the	most	interesting	mutations.	
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Summary.in.Swedish.
Kartläggning.av.MCOA.på.hästens.kromosom.6
Flera	 Kongenitala	 Okulära	 avvikelser	 (MCOA)	 är	 en	 sjukdom	 som	 drabbar	
främst	silverfärgade	hästar	av	raser	som	Rocky	och	Kentucky	Mountain	hästar.	
I	dessa	raser	är	silverfärgen	mycket	populär	vilket	har	lett	till	en	ökad	frekvens	
av	drabbade	hästar	inom	rasen.	�et	viktigaste	sjukdomssymptomet	är	okulära	
cystor	 av	 varierande	 storlek.	 Stora	 cystor	 leder	 även	 till	 en	 rad	 sekundära	
symptom	 exempelvis	 näthinneavlossning.	 I	 tidigare	 studier	 har	 ett	 lokus	 för	
MCOA	kartlagts	till	ett	intervall	på	420	kb	på	hästkromosom	sex.	Inom	detta	
intervall finns det ett antal gener inklusive PMEL17	vilken	bär	den	orsakande	
mutationen	för	pälsfärgen	silver.	�enna	studie	har	 fokuserat	på	att	korta	ned	
kromosomintervallet	 med	 Single	 Nucleotide	 Polymorphism	 (SNP)	 markörer.	
�etta	gjordes	genom	att	använda	polymorfa	SNP	markörer	 från	EcuCab	2,0.	
Genotypningen	 gjordes	med	 hjälp	 av	 förbeställda	 primers	 och	 prober	 i	 ABI	
7900HT	snabb	realtids�PCR�system.	Vid	bedömningen	av	resultatet	upptäcktes	
två	olika	 sjukdomshaplotyper,	 en	 längre	och	en	kortare.	�essa	 rekombinanta	
kromosomer	har	bidragit	till	att	minska	intervallet	med	37	%	vilket	resulterar	
i	ett	intervall	på	25	kb.	�etta	har	minskat	antalet	gener	som	skall	undersökas	
till	 sexton,	 inklusive	 PMEL17.	 Resultaten	 överensstämmer	 med	 hypotesen	
om	ett	codominant	nedärvningsmönster.	En	gen	inom	intervallet,	SMARCC2,	
valdes	 inom	 detta	 projekt	 för	 sekvensering	 på	 grund	 av	 dess	 inblandning	
i ögats utveckling. En polymorfism upptäcktes i intronet mellan exon nitton 
och	 tjugo.	 Fortsatta	 studier	 för	 att	 hitta	 den	 orsakande	 mutationen	 omfattar	
utökad	 undersökning	 av	 SMARCC2 polymorfismen, sekvensering av andra 
kandidatgener	samt	funktionsstudier	av	de	mest	intressanta	mutationerna.
Introduction
Ramsey	 et. al. first described congenital ocular abnormalities of the Rocky 
mountain	 horse in	 1999.	 The	 most	 predominant	 features	 of	 equine	Multiple	
Congenital	Ocular	Abnormalities	(MCOA)	are	cysts	of	variable	sizes	(2�20mm)	
originating	 from	 the	 posterior	 iris,	 ciliary	 body	 and	peripheral	 retina.	These	
cysts	 are	 found	 in	most	 horses	 affected	 by	MCOA	 and	 are	 usually	 bilateral.	
The	presences	of	large	cysts	in	the	eye	cause	a	number	of	secondary	symptoms.	
Another	 feature	 is	 dark	 pigmented	 curvilinear	 streaks	 of	 retinal�pigmented	
epithelium	 that	 cross	 the	 peripheral	 tapetal	 fundus	 from	 the	 peripheral	
retina	 to	 the	optic	papilla.	These	streaks	are	 the	remnants	of	previous	retinal	
dysplasia.	Veniform	folds	characterize	retinal	dysplasia	of	the	temporal	part	of	
the	peripheral	retina.		Total	detachment	of	the	retina	was	found	in	horses	that	
suffered	from	cysts	in	the	ciliar	body.	Here	the	retina	detaches	in	a	curvilinial	
streak	from	the	ciliar	body	stretching	toward	the	optic	papilla.	Horses	suffering	
from	some	or	all	of	these	symptoms	often	have	additional	ocular	abnormalities	
involving	 the	angels	of	 the	eye,	 iris	 abnormalities	or	 lenticular	cataracts.	All	
these	 abnormalities	 also	 lead	 to	 enlarged	 optical	 diameter	 and	 an	 irregular	
optical	shape,	cornea	globusa,	which	is	easily	observable	due	to	the	protrusion	
of	the	eyes.	Horses	affected	by	this	syndrome	seem	to	have	less	impaired	vision	
than	would	be	expected.	This	 could	be	explained	 in	part	by	 the	 fact	 that	 the	
intraocular	pressure	is	within	the	normal	range.	Horses	with	small	cysts	have	
normal	vision.	
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Picture	1,	A,	Right	eye	of	an	MCOA	affected	Rocky	Mountain	horse.	Two	large	ciliar	cysts	
are	visible	under	the	black	arrows,	the	white	arrows	point	to	the	elongated	ciliary	body.	B,	
Retinal	detachment	(large	arrows)	is	one	of	the	symptoms	of	MCOA.	Hyperpigmantation	
lines	mark	the	borders	of	previous	retinal	detachments.	C,	The	iridocorneal	angles	change	
due	to	the	ocular	cysts.	
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In	 the	 original	 study	 of	 MCOA	 the	 conclusion	 was	 that	 the	 phenotype	 is	
heritable	 since	 most	 cases	 came	 from	 the	 same	 breed	 lineages	 (Ramsey	 et. 
al.	1999).	Ewart	et. al.	2000	studied	the	inheritance	pattern	within	the	Rocky	
mountain	 breed	using	pedigree	 data	 including	51	 affected	 and	non�affected	
horses. This dataset best fitted the codominance model where both homozygous 
and	heterozygous	are	affected	although	the	level	of	severity	of	the	symptoms	
D
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Picture	2,	�,	An	eye	from	a	MCOA	affected	Rocky	Mountain	horse.	Note	the	size	difference	
and	the	irregular	form	compared	to	a	nonaffected	eye.	E,	An	eye	from	a	non	affected,	age	
correlated	Rocky	Mountain	 horse.	 F,	 The	 protrution	 of	 an	 eye	with	Cornea	Globosa	 is	
easily	visible	.	©	Ramsay	�T.
A B
Picture	2.	This	is	an	attempt	to	visualize	the	effect	that	the	cysts	may	have	on	the	eye	sight	of	
horses	affected	by	MCOA	(B)	compared	to	non�affected	horses	(A).	©	Ramsey	�T.
10
differ.	A	problem	occurring	in	the	study	is	that	heterozygous	horses	have	very	
small	cysts,	which	could	lead	to	false	negatives,	as	very	small	cysts	could	be	
difficult to detect. Recently however, another study was published with an 
alternative	hypothesis	regarding	the	inheritance	pattern	(Grahn,	B	et. al.	200).	
According	 to	 this	 dataset,	 which	 includes	 134	 horses	 of	 the	 Rocky	 and	 the	
Kentucky	Mountain	 breed,	 the	 inheritance	of	MCOA	 is	 autosomal	 dominant	
with	 incomplete	penetrance.	The	differences	of	 these	 two	hypotheses	can	be	
explained	in	part	by	a	slight	difference	in	the	phenotyping	of	the	cases	in	the	
two	studies	and	the	fact	that	different	controls	were	used.	The	latest	study	in	
the	area	also	point	 to	a	codominant	 inheritance	pattern	 (Andersson,	L	et. al.	
200).	 All	 studies	 do	 agree	 on	 the	 fact	 that	 Silver	 colored	 horses	 show	 the	
MCOA	phenotype	more	often	than	would	be	expected	by	chance.	
The	Silver	dapple	coat	color	is	caused	by	dilution	of	eumelanin.	This	is	most	
clearly	visible	in	the	long	hairs,	mane	and	tail,	which	are	diluted	into	a	gray	or	
flaxen color while the body hair remain darker.  The silver dapple coat color is 
associated	to	a	missense	mutation	in	exon	11	in	the	PMEL 17	gene	(Brunberg	
et. al. 200).	PMEL 17	mutations	have	been	detected	in	many	species	causing	
different	phenotypes	of	coat	color	dilutions.	It	is	also	a	candidate	gene	for	the	
MCOA	mutation,	due	 to	 the	physical	connection	 to	 the	 locus	for	MCOA,	and	
that	PMEL17	mutations	disturbance	of	melanin	pathways	cause	developmental	
ocular	 anomalies	 in	 other	 species	 (Schontaler	 et. al.	 2005).	 The	 reason	why	
MCOA was first found in the Rocky and the Kentucky mountain horses (RH 
and	KH)	 is	 that	 these	breeds	were	 recently	 created	by	using	 a	 few	 founding	
stallions.	This	increased	the	level	of	homozygosity.	Furthermore,	the	extended	
breeding	for	desired	traits	will	also	increase,	unevenly,	the	level	of	an	undesired	
trait	closely	connected	to	the	desired	trait.	In	the	case	of	RH	and	KH	the	desired	
trait	is	the	Silver	dapple	coat	color.	MCOA	have	been	detected	in	Silver	dapple	
colored	horses	 in	other	breeds	as	 the	Belgian	draft	horse,	 the	Morgan	horse,	
the	Shetland	pony	and	the	American	Miniature	horse	(Ramsay	�,	et. al.	1999).	
Including	these	breeds	into	the	study	may	help	to	diminish	the	interval	for	the	
location	of	the	causative	mutation.
Recently	the	phenotype	has	also	been	detected	in	the	Icelandic	horse	(Ekesten	
B,	et. al.	2009).	This	study	was	performed	by	close	opthalmologic	examination	
of	eleven	Icelandic	horses	including	both	homo�	and	heterozygotes	for	the	Silver	
mutation	as	well	as	non�carriers.	Of	the	horses	that	carried	the	mutation	three	
out	of	six	were	phenotyped	as	MCOA�affected	while	no	cysts	could	be	found	in	
the	eyes	of	the	non�carriers.
KATARINA	LYBERG
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C �Picture	3.	Silver	�apple	colored	horses	affected	with	MCOA	from	different	breeds.	A	�	Rocky	
mountain	horse,	B	�	American	Miniature	horse,	C	�	Belgian	Ardenne	and	�	�	Shetland	Pony.	
©	Ramsey	�T.
Picture	4,	A	Silver	
dapple	colored	
Icelandic	stallion.
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This	study	will	add	information	to	achieve	a	better	understanding	of	the	genetic	
components	 in	 the	 development	 of	 the	 ocular	 system.	 There	 are	 a	 number	
of	 ocular	 disorders	 in	 humans	 that	 are	 known	 to	 be	 inheritable.	The	 precise	
genetic	components	that	contribute	to	these	diseases	are	still	largely	unknown.	
There	is	no	exact	human	form	MCOA	but	there	are	a	number	of	disorders	where	
the	symptoms	show	similarities	to	the	symptoms	displayed	by	MCOA	affected	
horses.	 One	 example	 is	 Anterior	 Segment	 �ysgenesis	 (AS�)	 a	 collection	 of	
developmental	 irregularities	 in	 the	 anterior	 segment	 of	 the	 eye	 (Sowden	 J,	
2007).	These	symptoms	resemble	those	portrayed	by	horses	with	MCOA.	This	
study	intended	to	shorten	the	chromosome	interval	for	MCOA	and	examine	the	
possible candidate genes within the interval. This was done by fine-mapping 
using	single	nucleotide	polymorphisms	(SNP).	The	SNPs	were	chosen	from	the	
list	of	SNPs	published	during	the	development	of	the	equine	SNP	chip	that	is	
being	evaluated	at	present	(Mickelson	J.	et. al.	2009).	The	SNPs	were	detected	
by	comparing	the	nucleotides	at	each	position	in	the	individual	that	was	used	
for	 the	 genome	 sequencing.	 Additional	 SNPs	 were	 found	 in	 the	 genome	 by	
comparison	to	a	few	horses	of	seven	different	breeds	selected	to	represent	global	
diversity.	In	this	way	approximately	54	000	SNPs	could	be	detected.	I	intend	
to	 use	 ten	 of	 these	 SNPs	 evenly	 distributed	 in	 our	 interval	 of	 420	 kb.	 This	
interval	is	found	at	the	end	of	the	q�arm	of	equine	chromosome	.	It	is	located	
in	an	area	that	is	gene	dense	and	in	our	interval	alone;	there	are	2	genes,	one	
of	 them	 being	 the	PMEL17	 gene.	 	 The	 intention	 of	 this	 project	 is	 to	 narrow	
down	the	interval	and	evaluate	the	genes	in	the	new	interval.	To	do	this	both	
MCOA�affected	horsed	and	healthy	controls	will	 be	genotyped.	Since	we	do	
not	have	a	large	number	of	horses	with	known	MCOA	status	I	will	add	horses	
that	can	be	suspected	to	carry	the	mutation,	namely	Silver	colored	horses	from	
breeds	 known	 to	 carry	 the	 disease,	 as	well	 as	 breeds	 that	 express	 the	Silver	
dapple	phenotype	but	have	not	yet	been	investigated	for	MCOA	and	non�Silver	
colored	offspring	from	these	Silver	colored	horses.	The	latter	samples	will	be	
used in the hope of finding recombinants that can drastically reduce the interval 
where	the	causative	mutation	can	be	found.	The	method	I	have	chosen	is	high	
throughput	 real	 time	 PCR	 and	 allelic	 discrimination	with	 the	ABI	 7900	HT	
system	(Bookout	AL.	et. al. 200).
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Materials.and.methods
Horse.material
The	material	was	chosen	with	the	purpose	to	decrease	the	length	of	the	interval	
as	 much	 as	 possible.	 Genomic	 �NA	 prepared	 from	 horses	 phenotyped	 for	
MCOA	were	reused	from	previous	studies.	These	were	horses	with	full	MCOA,	
with	cysts	only	and	unaffected	horses.	The	horses	chosen	had	been	found	to	be	
recombinant	in	some	part	of	the	interval	in	the	previous	study.		Horses	from	the	
previous	study	that	had	for	some	reason	not	worked	perfectly	were	also	added	
to	the	material.	One	of	the	ideas	with	this	project	is	that	the	causative	mutation	
for	MCOA	is	very	close	 to	or	 the	same	as	 the	missense	mutation	 in	PMEL17	
that	causes	the	dilution	of	eumelanin	that	gives	the	Silver	dapple	coat	color.	For	
this	 reason	previously	non�genotyped	Silver	colored	horses	 from	both	breeds	
that	are	known	to	carry	the	syndrome		and	breeds	that	are	believed	to	carry	the	
disease were added to the material. In order to find a recombinant sample that 
could	help	decrease	the	interval,	more	drastically,	non�Silver	colored	offspring	
from	Silver	colored	horses	were	genotyped.	In	the	case	of	a	possibly	interesting	
recombinant	sample	this	horse	will	be	phenotyped.	In	Table	1	is	an	overview	
of	the	material.	
Breeds Number.of.horses
Horses.with.
MCOA
Silver.colored.
horses
Non.Silver.
colored offspring.
Icelandic.horses 237 1 132 65
Rocky.Mountain 76 31 61 0
Kentucky.Mountain 2 1 0 0
Morgan 8 0 4 3
American.Saddlebred 1 0 0 0
Mini 52 0 8 0
Ardenner 3 0 1 2
Swedish.Halfblod 2 0 2 0
Table	1,	General	overview	of	the	material
Extraction of DNA
�NA	from	hair	samples	was	extracted	using	the	Chelex	protocol	(Walsh	JL.	et. 
al. 1991). To approximately five hair-roots 93 µl of 5% chelex solution and 7 µl 
14
Picture	 5.	 A,	 Illustration	 of	 the	 original	 interval	 at	 horse	 chromosome	 	 including	 human	
synteny.	B,	Genes	in	the	previous	interval.	(Ensemble	release	54)
73.65 Mb 73.75 Mb 73.85 Mb 73.95 Mb
XP_001916652.1
XP_001504837.1
Q00AG8_HORSE
XP_001504840.1
XP_001504847.1
XP_001491902.2
XP_001917499.1
Q6X9Y4_HORSE
XP_001491946.1
Q6XA06_HORSE
XP_001504859.1
XP_001504861.1
XP_001504866.1
XP_001504865.1
XP_001492059.2
Q6X9Y2_HORSE
XP_001504877.1
XP_001504878.1
XP_001492082.2
COQ10A
Q0QEK7_HORSE
XP_001504883.1
XP_001504886.1
IL23A_HORSE
XP_001504891.1
XP_001492129.2
XP_001504893.2
Ensembl gene
73.65 Mb 73.75 Mb 73.85 Mb 73.95 Mb
There are currently 9 tracks turned off.
Ensembl Equus caballus version 54.2d (EquCab2) Chromosome 6: 73,607,795 - 74,029,118
421.32 Kb Forward strand
Reverse strand 421.32 Kb
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Proteinase	K	was	added.	The	proteinase	K	 reaction	was	performed	one	hour	
at	5°C	and	then	inactivated	in	95°C	for	10	minutes.	The	Chelex	are	magnetic	
beads	 that	 attract	 the	 remnant	 of	 the	 cell	 structures	 leaving	 the	�NA	 easily	
retrievable	in	the	supernatant.	�NA	from	blood	were	extracted	using	the	Gene	
Mole	 instument	 and	 the	Mole	 Strips DNA Blood Kit. 100 µl blood was 
eluated in 200 µl medium according to the manufacturer’s protocole.
SNP detection and evaluation
Using	 the	 Ecu.Cab	 2.0	 an	 additional	 nine	 SNPs	 other	 than	 those	 located	 in	
PMEL17	were	detected.	In	the	known	interval	markers	were	chosen	that	were	
evenly	distributed	with	a	distance	of	approximately	0	kb	inbetween.	We	placed	
two	of	the	markers	outside	of	the	interval	in	order	to	obtain	clear	borders	for	the	
haplotypes	when	 investigating	 the	 results.	These	SNPs	were	 investigated	via	
sequencing	to	evaluate	whether	or	not	they	were	polymorphic.	Primers	for	PCR	
and	 sequencing	were	 designed	 using	 the	 primer3plus	 software	 (Untergrasser	
A,	 et. al. 2007). The markers were amplified with touchdown PCR and the 
products	were	investigated	on	a	1.5	%	agarose	gel	in	2	%	S�S	buffer	at	90	Amp.	
As	reference,	a	1	kb	gene	ladder	was	used.	To	stain	the	�NA	the	gel	were	left	to	
soak	in	an	ethidium	bromide	bath	for	15	minutes.	The	gels	were	UV	illuminated	
and	recorded	using	Bio�Rads	Molecular	Imager	Chemi�oc	XRS+	System.	For	
primer	sequences	of	all	markers	used	in	this	project	please	view	appendix	1.
	
The	PCR	products	were	then	dephosphorylated	by	adding	calf	intestine	alkaline	
phosphate	 (CIAP)	 in	 preparation	 for	 the	 sequencing.	 For	 most	 markers	 the	
forward	primer	was	used	for	the	sequencing	but	in	a	few	cases	the	reverse	primer	
Picture	,	Control	of	PCR	products	by	agarose	gels.
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was	chosen	because	of	repetitive	parts	in	the	sequence	of	the	forward	primer.	
CodonCode	aligner	3.0.1	was	chosen	to	analyze	the	result	from	the	sequencing.	
The	program	aligns	the	sequences	allowing	for	a	quick	SNP	investigation.	For	
those	SNPs	that	turned	out	to	be	non�polymorphic,	alternatives	were	chosen	in	
the	proximity	and	investigated	in	the	same	way.	Appendix	2	PCR,	CIAP	and	
sequencing	protocol.
Genotyping
In	 order	 to	 receive	 a	 high	 throughput	 and	 fast	 genotyping,	 the	 7900HT	 fast	
real�time	PCR	system	from	Applied	Biosystems	(ABI)	was	chosen	for	PCR	and	
allelic	discrimination	 in	one	 step.	After	 investigating	 the	 sequence	using	 the	
repeat masker program and the filebuilder 2.0 program, custom made primers 
and sequence specific probes were ordered from ABI. 
Marker.
Name Sequence
NI1
AAAGTATGTAATAGCGAGCCCCTGAAGGGGAAGCAGCGTCATAGGT		
GAGG	(G/T)CCAGGTAGTAGTGATTCTGATGCGTAGCTGATTTGAAAA	
TACA
PMEL17
AGGATTTATTTCAGGTAATGGTAGTCTCCAAGGGAAGACTGGAGAC	
AAGAGAGGCATTGCTGTCCACACCTGGGTAAATCATGGCATCACAT	
GAGAGCACTCAGACCTGCTGCCCACTGAGGAGGGGGCTGCTCTCA	
CCAAAGGGGGAAGAGCGGAAGACCCAGGGCAGACGCAGCCAGTG	
GGTTCTACCGTGTGGCAGCTGGGGAAGGGGGAGAGCTGAGCCCTG	
CTTCATAAGTCTGCGCCTGATTTGGGAGAAGAAGAAGGAAACTGGT	
AAGCAATGGACAAGGGCAGCCTGTCTGTGCTTCTCCAAAGAAGAG	
GACACACCCACATCCCAGGTTTACTTGGCCTTGATCCTAGCTGCCTC	
CTCTTCTCCTCACAAACAGGGTTCATTTCTCTTGTTTATATGGTAACC	
TCTGTCCATTCCCCTCTCACTCTACAAGCTTCCCTGCTTTGAGGACGT
BIEC2-
1018345
TCCTGCTCGGAGTCTCTAAAAGCGCTAAGGAGCTCAGTGTCTAGGG	
ATTTCCAGATTTCTGAAAGGAGAGTGAACAGTCACTGCCAGATCAG	
GGTGGAATTAAAAGAGGCATGGGTGGGATTAAGGTAAAGGCCCCA	
AAGGAGAAATTCTGGAGTTGGAGTAGCAAGCAGATAGAAATGGTC	
ATAAGCTGGAGTTAGATA[C/]GAAATAGAGATGAGAAAGATCTCCTC	
ATCACCACCACCCCCCATTCTCCTGCCCAGACAAGGTCCCCATGAC	
TGCCCCTCCTCAGCTGGCCCTAGATCTGTGACATTCTCTAAATGGTT	
GGAATAGCCAGGAATGTAGGTCAGAGCTAGAGCCAGGGCTTTCTCC	
TCAATGGCTCCTCCCTCCTCCATCCCCGTCTCCAG
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BIEC2-
1018377
ACAGAACAACRCTTTATAACATTGCAGGCATTTAGTAKAGTAACTCC	
ATTTTTGGTACTTTTTAGTATTTTATGTTAGTGGTTTGGATCAGAAAA	
AACTTTTTTTTCTTCTTGCAGTTTATGGCTTCTGAGGCACTTGTGATC	
CCAGATACCAGTTTGAAACTTTTCGGTGGAATACCTCTTTGAGATCT	
GCTAAAAGCT[A/C]TAAGCTATGAGCCTGCTGAAGCCCAGGGACCTT	
AGATTAAGTCCCCTTGGATTATACACTTGTTTATGAGGAAATAAGTCT	
ACATAAATTGAAGTTACTAACATAATTGGGGTGTCTGAGAAGGGAA	
GAAGGTAGCATTTAACAGTGCATCAGCTTCGAGTCAGCATTTCCATG	
TCTCCTTCCTGTTGTCCCCAACGCCT
BIEC2-
1018453
GGGGCAGAGACAAAGCCAGGATCCTGACGTTCTTCTTTTCTTTCAG	
CTACCAGCTCTGCTTCGTCCTCCTGAGCCCCTCCCTACACTCGATGT	
GCTCCTGCAGGGGCTGGGCCTGCTGCTGGGGGGCAGCCTCATGCTC	
ACCATTGCCATGCTGGAGGAGCAGCTATGGCCCCTGGTCTCTGATG	
GCTGACGGGGGCCAG[T/]GGAAAGGCGTCCAGGTTGCCCTTCCTTC	
CCCCCAACCACAGGAATGGAGGCGGGACACAGGGCCAGTAGGAG	
CAATAGGATTTTAATAAACAGAACCCATCCCAAAGCCATGACTATG	
ACAGTTGTACTTGCACCAAACAGCATAGAAAACCAGGACGTGGTG	
GGAGGGCTCAAAGCGGTTGGGGGAGGACATGAGTAGG
BIEC2-
1018475
CAGTAGTTATAACGTTCTCCAAAACCTCCCTCCTGAGTCCTTCAATT	
CTCTCTCATATGACCACCTTCCCCGGAACCTTTCCCCATATCCCAGA	
GGGCTCCCGCTGGTATCCCCCAGCACCTTGCGGTATTTCTTAGAGA	
CCATGTGGAGATGTGGCTCCTCTTCCCGCCCTATTGGTGACTCAGTG	
ACCTGGCTGAAGC[AT]GTCAAATTCACTGTCTGACTCCTTGAGTCG	
GTAAGGAATCTAGAATTTTAAAAAAAGAGGTAAACTTGTTGGATGC	
CTTAATCCTCTTTGGTTTTCCCCTACCTTTATCCCAACACTGAAACA	
GCCAGCAAGTCCTGAACCTTCTAATTTCATAGGGTTTCCAGCATCCA	
CTCCTTCCTTTTTATTCGCATGGGTGTCAC
BIEC2-
1184963
GGCAGCTGGTTTCTGAACCCCTTGGGGTCAAATTCCTAAACCAAGA	
AGATGGGTTGAGTCAGAGGGTTTAATCTTGCCACCGTGGAGCAGGA	
ATGGGATAGCCTTATCAGCCGAGGCATCTGCCATCATCTGCTCTTCT	
TCATCCTCATGAAGCAATCCATTAGCTGCCCTGCGCTTGTCCTACCC	
TCCTTTTCCCACTT[T/C]CCAGAGATCCTAAGGGATTAGCCTTCTGAG	
CAGGTAGAGAGGAACTTACAGTAGTGAACTTGTGGATAGGGATGCG	
CTCCTGTCCCTCGGCAATAGTGTAGAAGAGCAGATCACCCAGGCGG	
GACAGCATGCCACTCTCTGAGGAATCACTGTTTGGGGCAGAGCCGG	
GGAGGAGGACAGGAACCTGAGAAGTGCTTCCT
Table	3	shows	the	sequences	used	to	order	primers	and	probes	both	from	Primer3plus	and	from	
ABI.
1
Sequencing of the SMARCC2 gene
When studying the genes in the final interval the SMARCC2	gene	was	chosen	
for	sequencing	because	of	its	importance	during	ocular	development.	This	gene	
contains	29	exons.	When	investigating	the	gene	using	the	UCSC	genome	browser	
a possible area for the promoter region was detected 890 bp upstream of the first 
exon.	 Primers	were	 ordered	 to	 cover	 all	 the	 exons,	 the	 promoter	 region	 and	
introns	15�20	since	they	are	more	conserved	than	other	areas.	Five	individuals	
were	chosen	for	the	sequencing,	three	with	MCOA	and	two	healthy.
Area covered by 
primerpair Direction Primersequences
Exon.29 Forward CCAGAACCTGAATCCCCTTT
. Reverse GAAGGACTTGGGGTTTGTCA
Exon.27.&.28 Forward CAGAGAGGCCCTTCCTCCT
. Reverse ATCCCTCCTCAAACCCAGAT
Exon.26 Forward TGCTGGCTCAGGGATATAACA
. Reverse ACTCCCTTGCAATGAGAAGC
Exon.25 Forward TCTAACAAGGGCCAAGCACT
. Reverse CTCCCTTCACCTCCTTCCTC
Exon.23.&.24 Forward TGGAAAGGAGAAGACAAGGAGA
. Reverse TAGTTCAGCTCAGGCAGCAA
Exon.21.&.22 Forward CTTACTTCGGGGTGATCTGG
. Reverse CCCCTGCTGGTCTAGATGAA
Exon.20 Forward CGTCACTTTGGCTGCTTCTT
. Reverse CTTGGAGATTCCCCTTGGAC
Exon.18.&.19 Forward GTACTCTGCTGGGTCCAAGG
. Reverse AAGAGCTGGATGACCTGGTG
Exon.17 Forward ACTTCCTCCCTTCCTGCTGT
. Reverse CAAGGGCCACAAGAATCAAC
Exon.16 Forward AGCCACATAACCTTTCTCCTCTT
. Reverse TTGGGTGTCACTGGCATTTA
Exon.15 Forward ACAGGGTTACATGGGACAGC
. Reverse GGAATGTTTGAACCCCTTGA
Exon.13.&.14 Forward CCTGTGGGCAAAAATCATGT
. Reverse TTTTGAGTCCTGGGGTTCAT
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Exon.11.&.12 Forward TAGCAACCCTCTGCCTCTTC
. Reverse CTGGCACCGAGAAGAATGAT
Exon.9.&.10 Forward GACTGTCCGTGGTGATGAAA
. Reverse GATTTCAGCCAAGACATTGACA
Exon.7.&.8 Forward TAGTTTCCGCCCTTCTTGTC
. Reverse GGGTGATTCTTGTCTTTCTTTTTC
Exon.5.&..6 Forward TCAGCCTAAGCCTCATCCAC
. Reverse TGTACACGTTCCGCTTCTTG
Exon.3.&.4 Forward CCTGTCACAACTGGGAAACA
. Reverse TCAGAAAAATGGCTGGGACT
Exon.2 Forward GGGATCTGGGGCTCACTAAT
. Reverse GATCTTGGGCAAGCCATTTA
Exon.1 Forward TGCCCAAGATCACAGAGACA
. Reverse TTCCATTGCCTGAACTCCAT
Promotor.region Forward CACACCCCTTTACCCAAGAA
. Reverse TCGACGAAATCCAAATGACA
Table	2,	Sequences	of	primers	used	when	sequencing	the	SMARCC2	gene.
20
Results
When	evaluating	the	markers,	nine	were	found	that	proved	to	be	polymorphic	
over	the	chromosomal	interval.	These	markers	are	not	as	evenly	distributed	as	
intended since there were some difficulties in finding polymorphic markers in 
parts	of	the	interval,	especially	in	its	3 e´nd.	In	this	area	the	sequence	seemed	to	
be	more	homozygous	than	in	the	surroundings	and	it	was	also	highly	repetitive.	
The	 data	 from	 these	 new	markers	were	 combined	with	 the	 data	 collected	 in	
previous	studies	to	obtain	a	good	resolution	of	the	chromosomal	interval.	
Marker Position.on.ch6 Distance.to.next. In.Kb
TKY.570 66793555 3795804 3795,804
TKY.412 70589359 2955419 2955,419
MS12 73544778 63017 63,017
MS1 73607795 32699 32,699
NI1 73640494 17674 17,674
MS14 73658168 7137 7,137
PMEL17 73665305 57316 57,316
MS3 73722621 3471 3,471
BIEC2-1018345 73726092 23403 23,403
MS7 73749495 18993 18,993
TKY.284 73768488 19523 19,523
BIEC2-1018377 73788011 47073 47,073
MS13 73835084 69868 69,868
BIEC2-1018453 73904952 63230 63,23
BIEC2-1018475 73968182 60936 60,936
MS21 74029118 34130 34,13
BIEC2-1184963 74063248 603761 603,761
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MS10 74667009 808225 808,225
MS11 75475234 753330 753,33
MS8 76228564 1522501 1522,501
MS9 77751065 1105381 1105,381
MS4 78856446 616429 616,429
TKY952 79472875 - -
Table	3,	Polymorphic	markers	used	to	map	the	interval.	New	SNPs	are	marked	in	green	and	the	
old	microsatellite	markers	are	marked	in	yellow.	The	borders	of	the	new	interval	are	marked	
with	a	thicker	line.
When	 genotyping	 the	 horses	with	 known	phenotype,	 two	 distinctive	 disease	
haplotypes	 could	 be	 detected.	 One	 shorter	 at	 25	 kb	 and	 one	 longer	 at	 420	
kb.	 The	 disease	 haplotypes	 were	 carried	 by	 9	%	 of	 the	 horses	 phenotyped	
with	 complete	MCOA.	Of	 the	 horses	 carrying	 one	 of	 the	 disease	 haplotypes	
5%	 carry	 it	 on	 both	 chromosomes.	 The	 horses	 that	were	merely	 displaying	
small	 ocular	 cysts	 9%	 carry	 the	 disease	 haplotype	 and	 of	 those	 97%	were	
heterozygous.	 In	 the	 group	 that	 were	 phenotyped	 as	 nonaffected	 only	 20%	
carry	a	disease	haplotype	and	in	those	cases	they	were	heterozygous.	
N1 PMEL17 8345 TKY284 8377 MS13 8453 8475 4963 MS21
T T C 177 C 222 G T C 261 Long.disease.hap
G T C 177 C 222 A A T 253 Short.disease.hap
Table	4,	The	disease	haplotypes.
The	sequencing	of	the	SMARCC2	gene	exposed	one	polymorphism	where	the	
MCOA	 affected	 horses	 and	 the	 healthy	 controls	 had	 different	 alleles.	 This	
polymorphism	is	located	in	the	intron	between	exon	19	and	20.	
Sample Phenotype Genotype
Is.1 MCOA CC
G11 Cyst GC
E11 Cyst GC
W1 Healthy GG
O3 Healthy GG
Table	5,	Result	of	the	SMARCC2	sequencing.
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Discussion
The	differences	 in	 length	of	 the	disease	haplotypes	 is	caused	by	the	fact	 that	
some	 of	 the	 affected	 horses	 are	 carrying	 a	 recombinant	 chromosome.	 This	
helped	 to	 decrease	 the	 interval	 by	 37	%,	 leaving	 an	 interval	 of	 25	 kb.	One	
reason	for	the	large	decrease	was	that	in	the	previous	study	the	markers	used	
were	microsatellites,	and	in	the	downstream	end	of	the	interval	there	were	large	
gaps	 between	 the	microsatellite	markers.	By	using	SNPs	 in	 this	 study,	 these	
gaps	 could	 be	 investigated	 and	 in	 a	 number	 of	markers	 found	 in	 these	 gaps,	
there	were	allelic	differences	within	 the	group	of	affected	horses.	Within	 the	
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GENE KNOWN/EXPECTED.FUNCTION
SLC39A5 Encodes	a	transmembrane	protein	that	is	probably	involved	in	zinc	transport.
OFC2B Is	a	vital	part	of	the	�NA	damage	control	system.
RNF41 Acts	by	regulating	degradation	of	its	targets,	one	of	those	being	the	ERBB3.
SMRCC2
Is an important part of five chromatin structure remodeling complexes. Has been 
proved to influence ocular development in other species.
MYL6B
Myosin light chain contributing to the sliding between filaments during muscle 
contraction.
FAM62A
A	transmembrane	protein	that	is	probably	activated	by	Ca2+.	The	Human	
homolog	is	extresses	in	the	entire	organism	but	enriched	in	the	brain.
ZC3H10
As a protein with a zinc finger domain the function of the protein is most likely 
to	be	regulation	of	transcription.
Pa2G4
The	biological	function	of	the	protein	is	probably	negative	regulation	of	
transcription.
ERBB3
A	tyrosine	kinase	that	is	very	important	during	cellular	development	and	
differentiation.	In	a	number	of	human	diseases,	causative	mutations	have	been	
detected	in	ERBB3
RPS26 Is	a	ribosomal	protein	and	thereby	important	for	translation.
IKZF4
A	�NA	binding	protein	that	interacts	with	MITF	andSPI1.	Is	expressed	primarily	
in	muscular	tissue	and	may	be	involved	in	neuronal	development.
SOUX
Sulfide oxidase that is crucial for normal function of the mitochondria. Lack of 
SOUX	protein	lead	to	irregular	brain	development	and	often	early	death.
RAB5B A	cell	membrane	protein	that	is	involved	in	protein	transport.
CDK2
A	phosphorylating	protein	that	is	activated	during	the	S	and	G2	part	of	the	
mitosis.
PMEL17
A	protein	important	for	the	formation	of	eumelanin.	Has	been	proven	to	be	down	
regulated	in	developmental	disorders	in	other	animals.
DGKA
A	part	of	the	intracellular	signal	transduction	following	activation	of	a	G�protein	
coupled	receptor.
Table	,	Genes	in	the	resulting	interval	and	known/predicted	protein	function.	(Ensemble	53)
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remaining	 interval	 there	are	 sixteen	genes	 still	 remaining	 to	be	 investigated,	
some	of	which	are	more	likely	to	be	involved	in	the	development	of	the	eye.	
SMARCC2	 is	 located	 in	 the	5´	end	of	 the	present	 interval,	approximately	179	
kb	from	the	Pmel17	mutation.	It	is	an	actin	dependent	�NA	binding	molecule	
that	is	a	vital	part	of	the	SWI/SNF	chromatin	regulating	complex	(Wang	W,	et. 
al. 1996). This complex has been proven to influence cellular differentiation 
in	a	number	of	tissues.	The	lentil	tissue	and	the	retina	is	an	example	of	tissues	
whose	normal	development	is	dependent	on	the	SWI/SNF	complex	(�uncan	B	
&	Zhao	K,	2007;	�as	A,	et. al.	2007).	In	many	types	of	cancer	the	SMARCC2	
gene	 is	 up�regulated	 and	 functions	 as	 an	 oncogene	 (Naidu	 S,	 et. al.	 2009).	
These	facts	make	it	a	very	interesting	candidate	for	 the	MCOA	 locus	and	are	
the	reason	why	this	gene	was	chosen	for	sequencing.	The	genomic	sequences	of	
three	horses	with	MCOA	and	two	healthy	controls	were	compared.	At	one	allele	
the	samples	were	different	from	the	controls.	This	allele	is	located	in	the	intron	
between	exons	19	and	20.	This	area	is	not	conserved	(conservation	score	0,		
according	to	UCSC,	phyloP44wayPlacMammal)	something	that	contradicts	the	
possibility	of	this	being	the	causative	mutation.	Therefore	this	intron	should	be	
investigated	 in	a	 larger	number	of	horses	 to	establish	 if	 the	polymorphism	 is	
completely	corresponding	to	the	phenotype	of	the	horse.	If	it	is	not	then	it	may	
be	used	to	further	decrease	the	interval.	
A	 strong	 candidate	 gene	 to	be	 the	 cause	of	 the	MCOA	 phenotype	 is	 still	 the	
pre�melanosomal	 protein	 17	 PMEL17.	 The	 PMEL17	 protein	 is	 vital	 for	 the	
formation	 of	 the	 eumelanosome	 (Chakraborty	A,	 et. al.	 199).	 The	 PMEL17	
protein	is	cleaved	and	then	polymerizes	to	form	a	grid	within	the	melanosome	
upon	where	the	eumelanin	granulates	assemble.	The	PMEL17	mutation,	which	
has	been	detected	as	 the	origin	of	 the	Silver	dapple	coat	color,	 is	a	missense	
mutation	in	exon	11.	This	lead	to	a	change	of	the	amino	acid	sequence	of		the	
proteins	 cytoplasmic	 region	 (Brunberg	 E,	 et. al.	 200).	 The	 melanosomal	
pathway	 is	 also	 important	 in	 the	embryonic	development	 and	differentiation.	
PMEL17 mutations	 can	 be	 found	 in	 a	 number	 of	 species	 for	 example	mouse	
and	dog,	giving	a	phenotype	of	diluted	eumelanin	coat	color.	In	some	cases	the	
animals	with	this	phenotype	also	display	various	phenotypes	of	developmental	
distortion.	In	dogs	the	coat	color	blue	merle	is	caused	by	a	mutation	in	PMEL17.	
Among	 dogs	with	 this	 coat	 color	 the	 prevalence	 of	 auditorial	 impairment	 is	
higher	(Clark	L,	et. al. 2006). In zebra fish the dilution of eumelanin leads to 
distorted	ocular	 development	 (Schontaler	H,	et. al.	 2005).	 In	 this	 dataset	 the	
PMEL17	SNP	matched	perfectly	to	the	disease	phenotype.
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Erythroblastic	 leukemia	 viral	 oncogene	 homolog	 3	 (ERBB3)	 is	 a	 membrane	
bound	epithelial	growth	factor	(Kraus	M,	et. al.	199).	It	binds	to	neuregulin	
and	 forms	 a	 heterodimer	with	 other	members	 of	 the	Erb	 family.	The	 kinetic	
activity	of	the	heterodimer	activated	a	number	of	pathways	important	for	cell	
proliferation and diversification. This is the reason why the gene is upregulated 
in	 a	 variety	 of	 cancer	 types	 (Chakraborty	 S,	 et. al.	 2007).	 The	 reason	 for	
ERBB3	 to	be	a	strong	candidate	 to	cause	 the	MCOA	phenotype	 is	because	of	
its importance in cellular development. This may influence the development of 
the eye. There are also some indications that the Erb group is influencing the 
expression	 of	PMEL17 due	 to	 the	 short	 distance	 between	 the	 loci.	 The	 third	
candidate	for	MCOA is the ikaros family zinc finger 4 (IKZF4). This is a DNA 
binding	transcription	factor	that	down�regulates	transcription	of	genes	involved	
in	bone	development	(Perdomo	J	&	Crossley	M	2002).	The	reason	for	it	to	be	
a	 candidate	 for	MCOA	 is	 that	 the	molecule	 that	 the	 IKZF4	 interacts	with	 is	
the	transcription	factor	MITF	(Hu	R, et. al.	2007).	This	complex	is	the	major	
regulator	 of	PMEL17	 transcription	 and	 if	 this	 complex	 is	 disrupted	 this	may	
influence the entire downstream interactions. 
In	this	study	the	phenotyped	horses	were	divided	into	three	groups.	The	horses	
of the first group had a number of ocular abnormalities, full-blown MCOA.  The 
second	group	constituted	horses	that	only	showed	small	ocular	cysts	and	the	third	
group	of	horses	were	those	where	no	ocular	abnormalities	had	been	detected.	
There	were	clear	genotypic	differences	between	the	three	groups.	In	the	MCOA	
group,	9%	were	homozygous	for	the	disease	haplotype	while	among	the	horses	
in	 the	cyst	group	93%	were	heterozygote	for	 the	same	haplotype.	Among	the	
horses	that	were	phenotyped	as	healthy	24	%	proved	to	be	heterozygote	for	the	
disease	allele.	These	horses	may	very	well	have	small	cysts	since	these	can	be	
difficult to detect. This result is consistent with the hypothesis of the inheritance 
pattern	being	codominant	with	incomplete	penetrance.	There	is	still	much	work	
left to be done in order to find the causative mutation for MCOA. The candidate 
genes	must	be	further	investigated	both	genetically	and	functionally.	When	the	
locus	has	been	found	then	the	breed	associations	that	are	affected	may	develop	
breeding	programs	that	avoid	mating	carriers	with	each	other.	
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Conclusion
The	primary	aim	of	this	project	was	primarily	to	diminish	the	interval	wherein	
to	 look	 for	 the	 MCOA	 locus.	 The	 resulting	 interval	 is	 approximately	 37%	
shorter	than	the	original.	Most	important	is	that	there	are	now	fewer	genes	to	
investigate.	 The	 gene	 chosen	 to	 be	 sequenced	 in	 this	 project,	 the	SMARCC2	
gene,	 hold	 an	 interesting	 polymorphism	 that	 needs	 to	 be	 explored	 further.	
Finding	 the	causative	mutation	and	 studying	 the	 function	of	 the	protein	may	
not	 only	 help	 animal	 breeders	 to	 generate	 a	 healthier	 stock	 but	 may	 also	
evolve	our	understanding	of	 the	complex	epigenetic	 regulation	during	ocular	
development.
2
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Appendix.1
All	Markers	tested	
Marker.name Position Forward. Reverse
BIEC2-1018319 73640354 GAAAAGGTGGGGGAAATAGC TGGCATGCAATTACAGCATT
BIEC2-1018290 73545965 AGGGAGTTGCCTTTGTTCCT TGTGGATTTGCTGGTGGTTA
BIEC2-1018299 73568548 GCTGGGGAAAATTTGAAAAA GTGCTTCAGGATGGGAATGT
BIEC2-1018307 73597316 CGGGGTTAGAATCTGTGCTC GGAACCCAACTACCCCCTAA
BIEC2-1018309 73604541 TTAAGAACCAGCTCCCCTCA GAGCTGAACTCAGAGCCACA
BIEC2-1018318 73640017 GCAGCGAGGAAATGGAAATA TACAGCACATGGCAGGAGAA
NI1 73640494 GAAAAGGTGGGGGAAATAGC TGGCATGCAATTACAGCATT
BIEC2-1018320 73640624 GGGCAGCATCAAAGGTAATC TGGTACAACCTCTTCTCCTGCT
PMEL17 73665305 CCTGGGTAAATCATGGCATC GTGAGAGGGGAATGGACAGA
BIEC2-1018345 73726092 AAGCGCTAAGGAGCTCAGTG CATTCCTGGCTATTCCAACC
BIEC2-1018377 73788011 TGTTAGTGGTTTGGATCAGAAAAA GGGACAACAGGAAGGAGACA
BIEC2-1018423 73857478 CAGAATCAATGGGACGGAGT TCTTCTGCACTGGGGCTACT
BIEC2-1018423 73857478 TTTCTTCCCAGTAATGTTTTTCTGT TCCTCAGTCTTGGTGGAGGT
BIEC2-1018424 73858845 CATGGGAAACGTAAAGTGGA GTGAGTGGATGGGTCAGGAG
BIEC2-1184873 73860926 TGGGAGACAGAGGAAGGAGA GGTTGAGGAAACAGGGTCAA
BIEC2-1184882 73871285 AGTGAGGGTGACGACAGGAG TTAACATAGGCAGGGCCAAG
BIEC2-1018453 73904952 TACCAGCTCTGCTTCGTCCT TACTCATGTCCTCCCCCAAC
BIEC2-1018454 73913915 GGGCAGTGAGAAGTCTAGGG CGCTGGTGAATCTGGATGTA
BIEC2-1018475 73968182 TTCTCCAAAACCTCCCTCCT GGATGCTGGAAACCCTATGA
BIEC2-1018509 74029403 GGAGTCAGCATGTCCTCCTC TCCCCATCTTCCTTTGGTAA
BIEC2-1184963 74063248 CCCTTGGGGTCAAATTCCTA TCAGAGAGTGGCATGCTGTC
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Appendix.2
PCR,	CIAP	and	Sequencing	protocol.
PCR.x 1 4 10
. . . .
H20 16,4 65,6 164
Mg 2,5 10 25
Buffert 2,5 10 25
dNTP 0,3 1,2 3
Taq 0,3 1,2 3
F.primer 0,5 2 5
R.primer 0,5 2 5
. 23 . .
DNA 2 . .
Reaction mix
Number: 1 50 20 25 40
Vol..PCR:. 25 25
CIAP 0,05 2,5 1 1,25 2
Exo1 0,1 5 2 2,5 4
Exo1.buffer 2 100 40 50 80
Tot 2,15 107,5
Mix -> 37°C, 1h -> 85°C, 15min-- GabSEQ på PTC2000
Sekvensering Primrar
späd.ca.5.ggr.(till.~100ng/ul) Start.c=.100uM
späd.10.ggr.(10+90).som.vid.vanlig.PCR
27 PCR.o.CIAP.mix
Späd.5ggr.
(10+40)
108 H2O
135
På.plattan
12.ul.vatten
4.ul.PCR.och.CIAP
2.ul.Primer
Allelic discrimination
384.platta,.dvs.5.ul.per.brunn
1 96 110 384 420
Master.mix 2,5 240 275 960 1050
Assay.mix 0,125 12 13,75 48 52,5
DNA.ca.4.ng/ul 2,375
